Issues in understanding childhood asthma.
Asthma and related allergic disorders in childhood have increased considerably in prevalence over the last few decades. During the same period of increasing morbidity from childhood asthma in the community, there have been dramatic advances in understanding of the basic immunopathologic features of the disease and consequently the development of a far more rational approach to its treatment. The immunopathologic condition of eosinophil-mediated airway inflammation is established very early in the evolution of asthma in childhood. It may even antedate the onset of symptoms. The present state of the art dictates that early intervention with potent therapies cannot be justified on the basis of symptoms alone and may in any case have no influence on the natural history of the condition. This means that current cautious therapeutic guidelines should continue to be followed. However, with the development of more accurate markers predicting ongoing disease, it will be possible to evaluate a whole range of early interventions in the future. Much evidence, though indirect, points to the possibility that the only true prophylaxis that will affect the natural history of asthma will need to be commenced before clinical features are manifest.
Warner
J O
JO
University of Southampton/Southampton General Hospital, United Kingdom.
Pohunek
P
P
Marguet
C
C
Roche
W R
WR
Clough
J B
JB
D001249:Asthma / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D001706:Biopsy; D001980:Bronchi / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002675:Child, Preschool; D006801:Humans; D007231:Infant, Newborn; D011379:Prognosis; D012135:Respiratory Sounds / Q000503:physiopathology; D013997:Time Factors